Cytosorbents’ (CTSO) Neutral Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their neutral rating on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday,Benzinga reports. The firm currently has a $1.00 price target on the medical research company’s stock. Several other brokerages have also commented on CTSO. StockNews.com started coverage on shares of Cytosorbents in a report on Tuesday, […]
HC Wainwright reissued their neutral rating on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report published on Thursday,Benzinga reports. The firm currently has a $1.00 price target on the medical research company’s stock. Several other brokerages have also commented on CTSO. StockNews.com started coverage on shares of Cytosorbents in a report on Tuesday, […]
